So bottom line for FY15 net profit BYOjet $242k and ibuynew $912k.BYOjet also has some impairments in that figure.So the future looks good.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game